Document Detail

A randomized invasive cardiac electrophysiology study of the combined ion channel blocker AZD1305 in patients after catheter ablation of atrial flutter.
MedLine Citation:
PMID:  20588189     Owner:  NLM     Status:  In-Process    
BACKGROUND: This study assessed the cardiac electrophysiological and hemodynamic effects of an intravenous infusion of the combined ion channel blocker AZD1305.
METHODS: After successful ablation of atrial flutter, patients were randomized to receive placebo (n = 12) or AZD1305 (n = 38) in 4 ascending dose groups. Electrophysiological and hemodynamic measurements were performed before and commencing 20 minutes after start of infusion.
RESULTS: Left atrial effective refractory period increased dose and the primary outcome measure increased dose and plasma concentration dependently, with a mean increase of 55 milliseconds in dose group 3. There was a corresponding increase in right atrial effective refractory period of 84 milliseconds. The right ventricular effective refractory period and the paced QT interval also increased dose and concentration dependently, by 59 and 70 milliseconds, respectively, in dose group 3. There were indications of moderate increases of atrial, atrioventricular nodal, and ventricular conduction times. No consistent changes in intracardiac pressures were observed, but there was a small transient decrease in systolic blood pressure. Adverse events were consistent with the study population and procedure, and there were no signs of proarrhythmia despite marked delay in ventricular repolarization in some individuals.
CONCLUSIONS: AZD1305 shows electrophysiological characteristics indicative of potential antiarrhythmic efficacy in atrial fibrillation.
Lauri Toivonen; Pekka Raatikainen; Håkan Walfridsson; Anders Englund; Finn Hegbom; Ole-Gunnar Anfinsen; Knut Gjesdal; Steen Pehrson; Susanne Johansson; Lars Frison; Anders R Berggren; Nils Edvardsson
Related Documents :
11446669 - Transesophageal echocardiography for detection of cardiac diseases in patients with ret...
667719 - The role of displacement of the mitral annulus in left atrial filling and emptying in t...
24020039 - Multiorgan with renal infarction following treatment of cerebral infarction.
9744439 - Prevention of atrial arrhythmias during ddd pacing by atrial overdrive.
12382079 - Electrophysiological and antiarrhythmic effects of the novel i(kur) channel blockers, s...
2643399 - Surgical techniques for the implantation of heterotopic prosthetic ventricles.
16213219 - Moody encodes two gpcrs that regulate cocaine behaviors and blood-brain barrier permeab...
1317989 - Mr imaging of experimental myocardial infarction.
25140699 - Morning surge of ventricular arrhythmias in a new arrhythmogenic canine model of chroni...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  56     ISSN:  1533-4023     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-09-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  300-8     Citation Subset:  IM    
Department of Cardiology, University Central Hospital, Helsinki, Finland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Cytochrome P450-derived epoxyeicosatrienoic acids and pulmonary hypertension: central role of transi...
Next Document:  Congestive heart failure: where homeostasis begets dyshomeostasis.